Assertio Holdings, Inc. (ASRT)
13.37
-0.35
(-2.55%)
USD |
NASDAQ |
Mar 20, 16:00
13.31
-0.06
(-0.45%)
After-Hours: 20:00
Assertio Holdings Research and Development Expense (Quarterly) : 0.486M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 13.44M |
| ANI Pharmaceuticals, Inc. | 12.26M |
| Alkermes Plc | 91.74M |
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| Aura Biosciences, Inc. | 22.18M |